Reply

Affiliations

¹ Clinical and Translational Science, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
² University of Western Ontario, CEO Robarts Clinical Trials, London, Ontario, Canada.

Comment

Miguel D Regueiro et al. Gastroenterology. 2016 Nov.

. 2016 Nov;151(5):1041-1042.

doi: 10.1053/j.gastro.2016.09.044. Epub 2016 Oct 3.

¹ Clinical and Translational Science, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
² University of Western Ontario, CEO Robarts Clinical Trials, London, Ontario, Canada.

No abstract available

Comment on

Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection.
Regueiro M, Feagan BG, Zou B, Johanns J, Blank MA, Chevrier M, Plevy S, Popp J, Cornillie FJ, Lukas M, Danese S, Gionchetti P, Hanauer SB, Reinisch W, Sandborn WJ, Sorrentino D, Rutgeerts P; PREVENT Study Group. Regueiro M, et al. Gastroenterology. 2016 Jun;150(7):1568-1578. doi: 10.1053/j.gastro.2016.02.072. Epub 2016 Mar 3. Gastroenterology. 2016. PMID: 26946343 Clinical Trial.
Is Early Endoscopy-Based Therapy the Best Strategy to Prevent All Crohn's Disease Postoperative Recurrence?
Sartini A, Scaioli E, Belluzzi A. Sartini A, et al. Gastroenterology. 2016 Nov;151(5):1040-1041. doi: 10.1053/j.gastro.2016.08.058. Epub 2016 Oct 1. Gastroenterology. 2016. PMID: 27702633 No abstract available.